Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy.

Lin C, Liu H, Zhang H, He H, Li H, Shen Z, Qin J, Qin X, Xu J, Sun Y.

Oncotarget. 2016 Aug 2;7(31):49281-49288. doi: 10.18632/oncotarget.10297.

2.

Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma.

Krenciute G, Krebs S, Torres D, Wu MF, Liu H, Dotti G, Li XN, Lesniak MS, Balyasnikova IV, Gottschalk S.

Mol Ther. 2016 Feb;24(2):354-63. doi: 10.1038/mt.2015.199. Epub 2015 Oct 30.

3.

Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy.

Seto K, Shoda J, Horibe T, Warabi E, Kohno M, Yanagawa T, Bukawa H, Nakanuma Y, Kawakami K.

Int J Hepatol. 2014;2014:584650. doi: 10.1155/2014/584650. Epub 2014 Apr 27.

4.

Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.

Skubitz AP, Taras EP, Boylan KL, Waldron NN, Oh S, Panoskaltsis-Mortari A, Vallera DA.

Gynecol Oncol. 2013 Sep;130(3):579-87. doi: 10.1016/j.ygyno.2013.05.027. Epub 2013 May 27.

5.

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.

Hall B, Nakashima H, Sun ZJ, Sato Y, Bian Y, Husain SR, Puri RK, Kulkarni AB.

J Transl Med. 2013 Feb 19;11:45. doi: 10.1186/1479-5876-11-45.

6.

A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.

Chugh R, Sangwan V, Patil SP, Dudeja V, Dawra RK, Banerjee S, Schumacher RJ, Blazar BR, Georg GI, Vickers SM, Saluja AK.

Sci Transl Med. 2012 Oct 17;4(156):156ra139. doi: 10.1126/scitranslmed.3004334.

7.

Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer.

Fujisawa T, Rubin B, Suzuki A, Patel PS, Gahl WA, Joshi BH, Puri RK.

PLoS One. 2012;7(4):e34437. doi: 10.1371/journal.pone.0034437. Epub 2012 Apr 20.

8.

Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Li X, Ma Q, Xu Q, Duan W, Lei J, Wu E.

Curr Pharm Des. 2012;18(17):2404-15. Review.

9.

A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models.

Nakashima H, Terabe M, Berzofsky JA, Husain SR, Puri RK.

J Immunol. 2011 Nov 15;187(10):4935-46. doi: 10.4049/jimmunol.1102095. Epub 2011 Oct 17.

10.

Supplemental Content

Support Center